Docencia

Birth outcomes for pregnant women with HIV using Tenofovir-Emtricitabine (03-12-2018)

Dra. Carmen Hidalgo. FEA de la Unidad de Gestión Clínica de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada

A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in adults with human immunodeficiency virus infection: an aids malignancy consortium trial (15-11-2018)

Dra. María Saumoy. Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario de Bellvitge, Barcelona

Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/ml (31-10-2018)

Dr.Pablo Ryan. Servicio de Medicina Interna. Hospital Universitario Infanta Leonor. Madrid

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study (15-10-2018)

Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía.

Phase 3 study of Ibalizumab for multidrug-resistant HIV-1 (01-10-2018)

Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid.

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults HIV-1 (DRIVE-FORWARD): 48- week results of a randomised, double-blind, phase 3, non inferiority trial (15-06-2018)

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial (01-06-2018)

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.

Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV (14-05-2018)

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial (05-05-2018)

Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial (16-04-2018)

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIVUninfected Adults in the United States: A Cross-Sectional Study (02-04-2018)

Dra. Ana Mariño. Unidad de VIH. Hospital Arquitecto Marcide-Novoa Santos, A Coruña.

Non Antiretrocial Polypharmacy and Adverse Health Outcomes Amon HIV. Infected and Uninfected Individuals (15-03-2018)

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial (01-03-2018)

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies (15-02-2018)

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance ofHIV viral suppression in patients with high cardiovascular (01-02-2018)

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review andmeta-regression analysis (18-01-2018)

Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older (01-01-2018)

Dr. Ana Mariño. Unidad de VIH del Hospital Arquitecto Marcide-Novoa Santos

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, noninferiority trial (15-12-2017)

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Antiretroviral combination use during pregnancy and the risk of major congenital malformations (01-12-2017)

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas Hospital Universitario y Politécnico la Fe, Valencia

Página 4 de 71234567

Accesos directos